(Q33289034)

25 July 2017

title

CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats (English)

1 reference

25 July 2017

Dieter Schmoll

7

0 references

Günter Müller

object named as

Günter Müller

6

0 references

author name string

Andreas W Herling

1

1 reference

25 July 2017

Matthias Gossel

2

1 reference

25 July 2017

Guido Haschke

3

1 reference

25 July 2017

Siegfried Stengelin

4

1 reference

25 July 2017

Johanna Kuhlmann

5

1 reference

25 July 2017

Werner Kramer

8

1 reference

25 July 2017

publication date

26 June 2007

1 reference

American Journal of Physiology - Endocrinology and Metabolism

25 July 2017

published in

1 reference

25 July 2017

volume

293

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

E826-32

1 reference

Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

The theoretical bases of indirect calorimetry: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Role of endogenous cannabinoids in synaptic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Cannabinoid physiology and pharmacology: 30 years of progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Serum resistin increases in a postprandial state during liquid meal challenge test in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Effects of cannabinoids on adrenaline release from adrenal medullary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

New insights into sympathetic regulation of glucose and fat metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Endocannabinoids as physiological regulators of colonic propulsion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

The emerging epidemic of obesity in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Systematic review: an evaluation of major commercial weight loss programs in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

New methods for calculating metabolic rate with special reference to protein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00264.2007

10.1152/AJPENDO.00264.2007

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference